Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) announced that its financial results for the second quarter of fiscal 2023, ending October 1, 2022, are now available on its Investor Relations website. A conference call and webcast will occur at 8:00 a.m. ET on November 7, 2022, to discuss these results. Interested parties can access the earnings release and supplemental information via provided links. A replay will be available for one year after the conference call. Haemonetics focuses on innovative medical products for improving patient care and reducing healthcare costs.
- None.
- None.
Financial release accessible online
BOSTON, Nov. 7, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal 2023, which ended October 1, 2022, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2022. The conference call and webcast can be accessed with the following information:
- Teleconference link: https://register.vevent.com/register/BI40288651d4b2472199bac5fd76e59174
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/jmqoyvd8
In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.
Direct link to 2Q FY23 Earnings Release:
https://haemonetics.gcs-web.com/static-files/f7bd49f3-53f3-412d-9e2f-a8793baa052b
Direct link to 2Q FY23 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/f02bd23c-d80b-491e-ab3a-f299118c93f3
A replay of the conference call and webcast will be available for one year beginning on November 7, 2022, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Sr. Director-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | 203) 733-4987 |
Media Contact: | |
Josh Gitelson, Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2023-earnings-release-available-on-investor-relations-website-301669873.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics report its Q2 fiscal 2023 results?
What time is the Haemonetics conference call for Q2 earnings?
Where can I find Haemonetics' Q2 fiscal 2023 earnings release?
How long will the replay of Haemonetics' conference call be available?
